Study of brenipatide for bipolar disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests an experimental drug called brenipatide for people with bipolar I or II disorder. It aims to see if the drug can help manage mood episodes when added to your current stable medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with bipolar I or bipolar II disorder
- You are on a stable dose of your current bipolar medications
- You are willing to inject the study drug yourself at home
- You can keep study diaries and fill out questionnaires
- You do not have schizophrenia, borderline personality disorder, or an eating disorder
- You do not have type 1 diabetes or a history of diabetic emergencies
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the study drug azetukalner can help reduce depression symptoms in people with bipolar I or II disorder who are currently having a depressive episode. You would be randomly assigned to receive either the drug or a placebo (inactive pill) to see which works better.
This study looks at how a ketogenic diet (very low carb, high fat) might affect brain function in people with bipolar disorder. Participants will follow the diet and have brain scans and blood tests to see how it helps mood and energy levels.
This study tests whether a ketone drink can change how the body uses energy in people with bipolar disorder. It may help understand new ways to manage the condition.
This trial tests a new medication, Brenipatide, to see if it helps people with major depression who are already on a stable treatment. You would need to inject the study drug yourself and complete questionnaires.
This study tests an investigational drug called Brenipatide for adults with major depressive disorder who are already on a stable antidepressant. You will receive the study drug as an injection and be monitored over time to see if it helps improve your depression symptoms.
This trial tests an investigational drug called brenipatide for people with schizophrenia who are already on a stable medication regimen. The goal is to see if adding this drug helps reduce relapses.
Hear when a new Bipolar Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.